Suhaina Supian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suhaina Supian has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Lina Rozano
Curtin Medical School, Curtin Health Innovation Research Institute, GPO Box U1987, Perth, WA 6845, Australia
2 shared publications Muhamad Aizuddin Ahmad
2 shared publications- Zuraida Ab Rahman
Biotechnology Research Centre, MARDI Headquarters, MARDI HQ, Persiaran MARDI-UPM, Serdang, Malaysia
2 shared publications A. Muhamad Aizuddin
1 shared publicationChien-Yeong Wee
MARDI, Biotechnol Res Ctr, Serdang 43400, Selangor, Malaysia
1 shared publicationLina Rozano
Malaysian Agr Regenrch & Dev Inst MARDI, Biotechnol & Nanotechnol Res Ctr, Serdang 43400, Selangor Darul, Malaysia
1 shared publication
Latest Publications
- Open Access
- 1 March 2024
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 12 (2) , 371-381
Kaempferia parviflora Wall. ex Baker against SARS-CoV-2 spike protein: In silico and in vitro studies
Context: SARS-CoV-2 spike (S) protein, governed by its receptor binding domain (RBD), is a key player in mediating viral attachment and fusion into host cells, which leads to infection and transmission of COVID-19. Searching for effective inhibitors against S RBD protein is essential to stop the virus infection. Aims: To evaluate Kaempferia parviflora’s bioactive compounds as inhibitors against SARS-CoV-2 S RBD protein and its complex with human angiotensin-converting enzyme 2 (ACE2) receptor through in silico, and to determine the ability of K. parviflora’s extract to inhibit the binding of S RBD and ACE2. Methods: Molecular docking was performed to evaluate the inhibition potentials of K. parviflora’s bioactive compounds against S RBD protein and its complex with ACE2. The inhibitory activity of K. parviflora’s extract against the binding of S RBD and ACE2 was determined using an in vitro inhibition assay. Results: K. parviflora’s compounds had inhibition potentials against S RBD protein in both closed and open states. In the open RBD, these compounds were bound to the key amino acids that were involved in the binding of RBD with ACE2, suggesting their possible roles in preventing the RBD-ACE2 association. K. parviflora’s compounds also had strong affinities towards the S RBD-ACE2 complex by interacting with the paired RBD-ACE2 amino acids, which were crucial for the S RBD-ACE2 complex’s stability. In addition, K. parviflora extract also demonstrated inhibitory activity against the binding of S RBD and ACE2. Conclusions: This study proposes K. parviflora as a promising inhibitor against SARS-CoV-2 S protein for the treatment of COVID-19.
- 1 March 2024
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 12 (2) , 371-381
Open AccessKaempferia parviflora Wall. ex Baker against SARS-CoV-2 spike protein: In silico and in vitro studies
Context: SARS-CoV-2 spike (S) protein, governed by its receptor binding domain (RBD), is a key player in mediating viral attachment and fusion into host cells, which leads to infection and transmission of COVID-19. Searching for effective inhibitors against S RBD protein is essential to stop the virus infection. Aims: To evaluate Kaempferia parviflora’s bioactive compounds as inhibitors against SARS-CoV-2 S RBD protein and its complex with human angiotensin-converting enzyme 2 (ACE2) receptor through in silico, and to determine the ability of K. parviflora’s extract to inhibit the binding of S RBD and ACE2. Methods: Molecular docking was performed to evaluate the inhibition potentials of K. parviflora’s bioactive compounds against S RBD protein and its complex with ACE2. The inhibitory activity of K. parviflora’s extract against the binding of S RBD and ACE2 was determined using an in vitro inhibition assay. Results: K. parviflora’s compounds had inhibition potentials against S RBD protein in both closed and open states. In the open RBD, these compounds were bound to the key amino acids that were involved in the binding of RBD with ACE2, suggesting their possible roles in preventing the RBD-ACE2 association. K. parviflora’s compounds also had strong affinities towards the S RBD-ACE2 complex by interacting with the paired RBD-ACE2 amino acids, which were crucial for the S RBD-ACE2 complex’s stability. In addition, K. parviflora extract also demonstrated inhibitory activity against the binding of S RBD and ACE2. Conclusions: This study proposes K. parviflora as a promising inhibitor against SARS-CoV-2 S protein for the treatment of COVID-19.
- 8 December 2022
- Published by Rynnye Lyan Resources in Food Research
- Vol. 6 (Supplement) , 83-90
Molecular docking and in silico drug-likeness studies of Garcinia prainiana King bioactive compounds as pancreatic lipase inhibitors
Garcinia prainiana King is an underutilized local fruit possessing high value in numerous therapeutic uses. Unlike other Garcinia species such as G. cambogia and G. atroviridis, the anti-obesity effect of G. prainiana has never been evaluated. Thus, in the present study, the inhibitory potential of bioactive compounds from G. prainiana towards pancreatic lipase, an enzyme involved in fat digestion that caused obesity was evaluated. A molecular docking study of eleven G. prainiana bioactive compounds against pancreatic lipase was performed followed by in silico drug-likeness prediction using the SwissADME tool. The docking study demonstrated that amentoflavone is the top compound showing the highest inhibition activity towards pancreatic lipase compared to other compounds. Two hydrogen bonds were formed between amentoflavone and two catalytic residues, Ser152 and His263 of pancreatic lipase. The formation of hydrophobic interactions with the lid residues, Ala260 and Ala259, may also contribute to the inhibitory effect of this compound. Other than amentoflavone, 4‴-methylamentoflavone and naringenin 7-o-β-D-glucuronide also exhibited high inhibition activities against pancreatic lipase by interacting with the catalytic and lid residues through hydrogen bonds. However, in the context of drug developability, naringenin 7-o-β-D-glucuronide was predicted to have a higher potential to be an oral drug candidate compared to amentoflavone and 4‴-methylamentoflavone. In conclusion, this study indicated the potential of G. prainiana compounds, particularly amentoflavone, 4‴- methylamentoflavone and naringenin 7-o-β-D-glucuronide as new pancreatic lipase inhibitors. However, naringenin 7-o-β-D-glucuronide has a higher drug-likeness potential that could serve as a drug candidate for the development of an anti-obesity agent.
- 8 December 2022
- Published by Rynnye Lyan Resources in Food Research
- Vol. 6 (Supplement) , 83-90
Molecular docking and in silico drug-likeness studies of Garcinia prainiana King bioactive compounds as pancreatic lipase inhibitors
Garcinia prainiana King is an underutilized local fruit possessing high value in numerous therapeutic uses. Unlike other Garcinia species such as G. cambogia and G. atroviridis, the anti-obesity effect of G. prainiana has never been evaluated. Thus, in the present study, the inhibitory potential of bioactive compounds from G. prainiana towards pancreatic lipase, an enzyme involved in fat digestion that caused obesity was evaluated. A molecular docking study of eleven G. prainiana bioactive compounds against pancreatic lipase was performed followed by in silico drug-likeness prediction using the SwissADME tool. The docking study demonstrated that amentoflavone is the top compound showing the highest inhibition activity towards pancreatic lipase compared to other compounds. Two hydrogen bonds were formed between amentoflavone and two catalytic residues, Ser152 and His263 of pancreatic lipase. The formation of hydrophobic interactions with the lid residues, Ala260 and Ala259, may also contribute to the inhibitory effect of this compound. Other than amentoflavone, 4‴-methylamentoflavone and naringenin 7-o-β-D-glucuronide also exhibited high inhibition activities against pancreatic lipase by interacting with the catalytic and lid residues through hydrogen bonds. However, in the context of drug developability, naringenin 7-o-β-D-glucuronide was predicted to have a higher potential to be an oral drug candidate compared to amentoflavone and 4‴-methylamentoflavone. In conclusion, this study indicated the potential of G. prainiana compounds, particularly amentoflavone, 4‴- methylamentoflavone and naringenin 7-o-β-D-glucuronide as new pancreatic lipase inhibitors. However, naringenin 7-o-β-D-glucuronide has a higher drug-likeness potential that could serve as a drug candidate for the development of an anti-obesity agent.
- Open Access
- 1 November 2022
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 10 (6) , 1103-1116
Phyllanthus tenellus Roxb. and Kaempferia parviflora Wall. ex Baker compounds as inhibitors of SARS-CoV-2 main protease and RNA-dependent RNA polymerase: A molecular docking study
J. Pharm. Pharmacogn. Res., vol. 10, no. 6, pp. 1103-1116, November-December 2022. DOI: https://doi.org/10.56499/jppres22.1485_10.6.1103 Original Article Phyllanthus tenellus Roxb. and Kaempferia parviflora Wall. ex Baker compounds as inhibitors of SARS-CoV-2 main protease and RNA-dependent RNA polymerase: A molecular docking study [Compuestos de Phyllanthus tenellus Roxb. y Kaempferia parviflora Wall. ex Baker como inhibidores de la proteasa Phyllanthus tenellus Roxb. and Kaempferia parviflora Wall. ex Baker compounds as inhibitors of SARS-CoV-2 main protease and RNA-dependent RNA polymerase: A molecular docking study.
- 1 November 2022
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 10 (6) , 1103-1116
Open AccessPhyllanthus tenellus Roxb. and Kaempferia parviflora Wall. ex Baker compounds as inhibitors of SARS-CoV-2 main protease and RNA-dependent RNA polymerase: A molecular docking study
J. Pharm. Pharmacogn. Res., vol. 10, no. 6, pp. 1103-1116, November-December 2022. DOI: https://doi.org/10.56499/jppres22.1485_10.6.1103 Original Article Phyllanthus tenellus Roxb. and Kaempferia parviflora Wall. ex Baker compounds as inhibitors of SARS-CoV-2 main protease and RNA-dependent RNA polymerase: A molecular docking study [Compuestos de Phyllanthus tenellus Roxb. y Kaempferia parviflora Wall. ex Baker como inhibidores de la proteasa Phyllanthus tenellus Roxb. and Kaempferia parviflora Wall. ex Baker compounds as inhibitors of SARS-CoV-2 main protease and RNA-dependent RNA polymerase: A molecular docking study.
- 30 September 2021
- Published by Penerbit Universiti Kebangsaan Malaysia (UKM Press) in Sains Malaysiana
- Vol. 50 (9) , 2591-2602
In-Silico Characterization and Expression Analysis of NB-ARC Genes in Response to Erwinia mallotivora in Carica papaya
Disease resistance in plants is commonly associated with resistance (R) genes that encode nucleotide binding site-leucine rich repeat (NBS-LRR) domains that are essential for pathogen recognition and defence signalling. In this study, we identified and analyzed the sequence of putative pathogen-responsive NB-ARC transcripts from Carica papaya transcriptome database, carried out the structural and phylogenetic analysis, and determined the expression profile of the transcripts in C. papaya challenged with Erwinia mallotivora. The findings indicate CpNBS1, the only pathogen-responsive NB-ARC protein identified in this study belongs to the CC-NBS-LRR group. Semi-quantitative PCR showed CpNBS1 was differentially expressed in response to E. mallotivora. Structural analysis of the 4993-Eksotika and 4993-Viorica translated proteins showed striking differences in terms of the number of β-sheets and α-helixes as well their ligand-binding surface, suggesting the role of the LRR domain in determining the specificity of recognition of E. mallotivora effector. Collectively, this study provides new insights into the role of NBS-LRR genes in C. papaya and its implications for enhancing of plant disease resistance through genetic engineering.
- 30 September 2021
- Published by Penerbit Universiti Kebangsaan Malaysia (UKM Press) in Sains Malaysiana
- Vol. 50 (9) , 2591-2602
In-Silico Characterization and Expression Analysis of NB-ARC Genes in Response to Erwinia mallotivora in Carica papaya
Disease resistance in plants is commonly associated with resistance (R) genes that encode nucleotide binding site-leucine rich repeat (NBS-LRR) domains that are essential for pathogen recognition and defence signalling. In this study, we identified and analyzed the sequence of putative pathogen-responsive NB-ARC transcripts from Carica papaya transcriptome database, carried out the structural and phylogenetic analysis, and determined the expression profile of the transcripts in C. papaya challenged with Erwinia mallotivora. The findings indicate CpNBS1, the only pathogen-responsive NB-ARC protein identified in this study belongs to the CC-NBS-LRR group. Semi-quantitative PCR showed CpNBS1 was differentially expressed in response to E. mallotivora. Structural analysis of the 4993-Eksotika and 4993-Viorica translated proteins showed striking differences in terms of the number of β-sheets and α-helixes as well their ligand-binding surface, suggesting the role of the LRR domain in determining the specificity of recognition of E. mallotivora effector. Collectively, this study provides new insights into the role of NBS-LRR genes in C. papaya and its implications for enhancing of plant disease resistance through genetic engineering.
- 1 April 2017
- Published by Elsevier in Physiological and Molecular Plant Pathology
- Vol. 98, 37-45
Antioxidant-mediated response of a susceptible papaya cultivar to a compatible strain of Erwinia mallotivora
- 1 April 2017
- Published by Elsevier in Physiological and Molecular Plant Pathology
- Vol. 98, 37-45
Antioxidant-mediated response of a susceptible papaya cultivar to a compatible strain of Erwinia mallotivora